Skip Header

1 - 25 of 68 results for author:"Marra M.A." in Literature citations

Page of 3 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (157,925)

ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.

Jiang Q., Crews L.A., Barrett C.L., Chun H.J., Court A.C., Isquith J.M., Zipeto M.A., Goff D.J., Minden M., Sadarangani A. et al.

Proc. Natl. Acad. Sci. U.S.A. 110:1041-1046(2013) · Mapped (6)

Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II.

Cheng S.W., Kuzyk M.A., Moradian A., Ichu T.A., Chang V.C., Tien J.F., Vollett S.E., Griffith M., Marra M.A., Morin G.B.

Mol. Cell. Biol. 32:4691-4704(2012) · Mapped (5)

Twist1 transcriptional targets in the developing atrio-ventricular canal of the mouse.

Vrljicak P., Cullum R., Xu E., Chang A.C., Wederell E.D., Bilenky M., Jones S.J., Marra M.A., Karsan A., Hoodless P.A.

PLoS ONE 7:e40815-e40815(2012) · Mapped (41)

TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma.

Scott D.W., Mungall K.L., Ben-Neriah S., Rogic S., Morin R.D., Slack G.W., Tan K.L., Chan F.C., Lim R.S., Connors J.M. et al.

Blood 119:4949-4952(2012) · Mapped (7)

Penetrance of biallelic SMARCAL1 mutations is associated with environmental and genetic disturbances of gene expression.

Baradaran-Heravi A., Cho K.S., Tolhuis B., Sanyal M., Morozova O., Morimoto M., Elizondo L.I., Bridgewater D., Lubieniecka J., Beirnes K. et al.

Hum. Mol. Genet. 21:2572-2587(2012) · Mapped (200)

MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.

Astanehe A., Finkbeiner M.R., Krzywinski M., Fotovati A., Dhillon J., Berquin I.M., Mills G.B., Marra M.A., Dunn S.E.

Oncogene 31:4434-4446(2012) · Mapped (2)

14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.

Lee C.H., Ou W.B., Marino-Enriquez A., Zhu M., Mayeda M., Wang Y., Guo X., Brunner A.L., Amant F., French C.A. et al.

Proc. Natl. Acad. Sci. U.S.A. 109:929-934(2012) · UniProtKB (2) · Mapped (5)

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.

Kridel R., Meissner B., Rogic S., Boyle M., Telenius A., Woolcock B., Gunawardana J., Jenkins C., Cochrane C., Ben-Neriah S. et al.

Blood 119:1963-1971(2012) · Mapped (3)

BCL2 mutations in diffuse large B-cell lymphoma.

Schuetz J.M., Johnson N.A., Morin R.D., Scott D.W., Tan K., Ben-Nierah S., Boyle M., Slack G.W., Marra M.A., Connors J.M. et al.

Leukemia 26:1383-1390(2012) · Mapped (4)

Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.

Heravi-Moussavi A., Anglesio M.S., Cheng S.W., Senz J., Yang W., Prentice L., Fejes A.P., Chow C., Tone A., Kalloger S.E. et al.

N. Engl. J. Med. 366:234-242(2012) · UniProtKB (1) · Mapped (5)

Mutations in EZH2 cause Weaver syndrome.

Gibson W.T., Hood R.L., Zhan S.H., Bulman D.E., Fejes A.P., Moore R., Mungall A.J., Eydoux P., Babul-Hirji R., An J. et al.

Am. J. Hum. Genet. 90:110-118(2012) · UniProtKB (1) · Mapped (8)

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers.

Yip S., Butterfield Y.S., Morozova O., Chittaranjan S., Blough M.D., An J., Birol I., Chesnelong C., Chiu R., Chuah E. et al.

J. Pathol. 226:7-16(2012) · Mapped (14)

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.

Morin R.D., Mendez-Lago M., Mungall A.J., Goya R., Mungall K.L., Corbett R.D., Johnson N.A., Severson T.M., Chiu R., Field M. et al.

Nature 476:298-303(2011) · Mapped (6)

Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalities.

Schrader K.A., Heravi-Moussavi A., Waters P.J., Senz J., Whelan J., Ha G., Eydoux P., Nielsen T., Gallagher B., Oloumi A. et al.

J. Pathol. 225:12-18(2011) · Mapped (8)

Retinoblastoma-binding proteins 4 and 9 are important for human pluripotent stem cell maintenance.

O'Connor M.D., Wederell E., Robertson G., Delaney A., Morozova O., Poon S.S., Yap D., Fee J., Zhao Y., McDonald H. et al.

Exp. Hematol. 39:866-79.e1(2011) · Mapped (2)

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.

Steidl C., Shah S.P., Woolcock B.W., Rui L., Kawahara M., Farinha P., Johnson N.A., Zhao Y., Telenius A., Neriah S.B. et al.

Nature 471:377-381(2011) · Mapped (9)

Genome and transcriptome analyses of the mountain pine beetle-fungal symbiont Grosmannia clavigera, a lodgepole pine pathogen.

DiGuistini S., Wang Y., Liao N.Y., Taylor G., Tanguay P., Feau N., Henrissat B., Chan S.K., Hesse-Orce U., Alamouti S.M. et al.

Proc. Natl. Acad. Sci. U.S.A. 108:2504-2509(2011) · UniProtKB (8,311)

Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.

Yap D.B., Chu J., Berg T., Schapira M., Cheng S.W., Moradian A., Morin R.D., Mungall A.J., Meissner B., Boyle M. et al.

Blood 117:2451-2459(2011) · Mapped (9)

Deep annotation of Drosophila melanogaster microRNAs yields insights into their processing, modification, and emergence.

Berezikov E., Robine N., Samsonova A., Westholm J.O., Naqvi A., Hung J.H., Okamura K., Dai Q., Bortolamiol-Becet D., Martin R. et al.

Genome Res. 21:203-215(2011) · Mapped (16)

Hypomorphic temperature-sensitive alleles of NSDHL cause CK syndrome.

McLarren K.W., Severson T.M., du Souich C., Stockton D.W., Kratz L.E., Cunningham D., Hendson G., Morin R.D., Wu D., Paul J.E. et al.

Am. J. Hum. Genet. 87:905-914(2010) · UniProtKB (1) · Mapped (4)

Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.

Cheung K.J., Johnson N.A., Affleck J.G., Severson T., Steidl C., Ben-Neriah S., Schein J., Morin R.D., Moore R., Shah S.P. et al.

Cancer Res. 70:9166-9174(2010) · Mapped (6)

System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma.

Morozova O., Vojvodic M., Grinshtein N., Hansford L.M., Blakely K.M., Maslova A., Hirst M., Cezard T., Morin R.D., Moore R. et al.

Clin. Cancer Res. 16:4572-4582(2010) · Mapped (3)

Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver.

Hoffman B.G., Robertson G., Zavaglia B., Beach M., Cullum R., Lee S., Soukhatcheva G., Li L., Wederell E.D., Thiessen N. et al.

Genome Res. 20:1037-1051(2010) · Mapped (15)

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.

Morin R.D., Johnson N.A., Severson T.M., Mungall A.J., An J., Goya R., Paul J.E., Boyle M., Woolcock B.W., Kuchenbauer F. et al.

Nat. Genet. 42:181-185(2010) · UniProtKB (1)

Genomic analysis distinguishes phases of early development of the mouse atrio-ventricular canal.

Vrljicak P., Chang A.C., Morozova O., Wederell E.D., Niessen K., Marra M.A., Karsan A., Hoodless P.A.

Physiol. Genomics 40:150-157(2010) · Mapped (34)

to top of page·

Page of 3 | Next »